Clinical trial
Oral Cladribine B-cell Study
NCT06415864 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Cladribine B-cell Study
- Lead sponsor
- Queen Mary University of London
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2019
- Completion date
- January 31, 2024
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.